Nature Conference: Innovative Tissue Therapies from Bench to Bedside

Register for #NatconfTissue21, organized by Nature Communications, to hear from an international panel of speakers as they share their latest advancements in tissue engineering, gene therapy, cell therapy, and innovative clinical treatments.
Nature Conference: Innovative Tissue Therapies from Bench to Bedside
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

At an upcoming virtual Nature Conference, Innovative Tissue Therapies from Bench to Bedside, we will hear from scientists developing innovative pre-clinical approaches in the realm of gene therapy, cell therapy and tissue engineering. Similarly, clinical researchers will give their perspective on the application of the most promising innovative treatments in human patients. 

Event Details 
November 16-18, 2021
07:00 EST (New York) | 12:00 GMT (London) | 13:00 CST (Milan) | 20:00 CST (Shanghai)

Presented by: I.R.C.C.S Ospedale San Raffaele and Nature Communications

Register now and be sure to submit your abstract by the September 20th deadline!

Learn more

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With collections, you can get published faster and increase your visibility.

Applications of Artificial Intelligence in Cancer

In this cross-journal collection between Nature Communications, npj Digital Medicine, npj Precision Oncology, Communications Medicine, Communications Biology, and Scientific Reports, we invite submissions with a focus on artificial intelligence in cancer.

Publishing Model: Open Access

Deadline: Mar 31, 2025

Biology of rare genetic disorders

This cross-journal Collection between Nature Communications, Communications Biology, npj Genomic Medicine and Scientific Reports brings together research articles that provide new insights into the biology of rare genetic disorders, also known as Mendelian or monogenic disorders.

Publishing Model: Open Access

Deadline: Apr 30, 2025